Hui Han

9PUBLICATIONS
58CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 13, 2025
Anti-epidermal growth factor receptor monoclonal antibody combined with chemotherapy in penile cancer: A prospective, multicenter, phase 1 study.

Pei Shu, Shuang Zhang, Dingwei Ye

|May 20, 2025
Decoding the impact of MMP1+ malignant subsets on tumor-immune interactions: insights from single-cell and spatial transcriptomics.

Da-Ming Xu, Ling-Xiao Chen, Ting Xue

|Jul 14, 2024
Altered tumor microenvironment heterogeneity of penile cancer during progression from non-lymphatic to lymphatic metastasis.

Da-Ming Xu, Xiao-Yu Zhuang, Hua-Li Ma

|Dec 29, 2023
Human papillomavirus infection affects treatment outcomes and the immune microenvironment in patients with advanced penile squamous cell carcinoma receiving programmed cell death protein 1 inhibitor-based combination therapy.

Lichao Wei, Zaishang Li, Shengjie Guo

|Sep 22, 2023
Mitochondria-ER contact mediated by MFN2-SERCA2 interaction supports CD8+ T cell metabolic fitness and function in tumors.

Jie-Feng Yang, Xudong Xing, Li Luo

|Oct 20, 2022
Extracellular Vesicle-Mediated Transfer of LncRNA IGFL2-AS1 Confers Sunitinib Resistance in Renal Cell Carcinoma.

Yihui Pan, Xuanxuan Lu, Guannan Shu

Pageof 2

Frequent Collaborators

2 joint publications

Yihui Pan

2 joint publications

Shengjie Guo

1 joint publications

Xiheng Hu

1 joint publications

Zhiyong Li